SINGAPORE (Reuters) -Asia shares got off to a shaky start on Friday after U.S. President Donald Trump unveiled a fresh round of punishing tariffs and as traders pared bets of sharp U.S. rate cuts following stronger-than-expected economic data. Trump on T

US stocks were on track for their third day of losses as bond yields spiked and AI excitement wore thin.

These two have a long track record of reliable dividends besides high yield.

HSBC said it used IBM's quantum tech in bond trading. IBM stock popped on the news as investors cheered real-world use for quantum computing.

Investors digested Trump's new tariff salvo, and the latest reading of the Fed's preferred inflation gauge, which showed prices rising as expected.

Shares of networking chips designer Marvell Technology (NASDAQ: MRVL) jumped 5% in the afternoon session after the stock's positive momentum continued as the company announced a new $5 billion stock repurchase authorization and a $1 billion accelerated sh

Shares of IT distribution giant TD SYNNEX (NYSE:SNX) jumped 5.3% in the afternoon session after the company reported third-quarter results that surpassed analyst expectations and provided a strong forecast for the fourth quarter.

A major auto seller's stock plummeted on Thursday, Sept. 25, 2025, while a semiconductor giant got a boost from reported talks with a top tech firm.

Shares of self defense company AXON (NASDAQ:AXON) jumped 2.9% in the afternoon session after it announced a deal to acquire Prepared, an AI-powered emergency communications company.

Shares of government and sustainable technology solutions company KBR (NYSE:KBR) fell 5.5% in the afternoon session after the stock's weakness continued as the company announced a plan to spin off its Mission Technology Solutions (MTS) business, a move th

Shares of radiation safety company Mirion (NYSE:MIR) fell 7.9% in the afternoon session after it announced plans to acquire Paragon Energy Solutions for about $585 million, revealed plans for a $600 million capital raise, and lowered its 2025 revenue grow

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.1% in the afternoon session after the company halted a mid-stage clinical trial for its experimental drug, bimagrumab, which was intended to prevent muscle loss in patients taking its blo

Plus, three Israel-based stocks to buy for Yom Kippur.

Customer experience solutions provider Concentrix (NASDAQ:CNXC) announced better-than-expected revenue in Q3 CY2025, with sales up 4% year on year to $2.48 billion. Guidance for next quarter’s revenue was better than expected at $2.54 billion at the midpo

Costco Wholesale (COST) exceeded fourth quarter earnings estimates, reporting revenue of $86.16 billion (vs. estimates of $86.03 billion) and adjusted earnings of $5.87 per share (vs. estimates of $5.82).\\n\\nYahoo Finance senior reporter Brooke DiPalma